Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dibekacin: diffusion in bronchial mucus]

C Morel, M Vergnaud, M M Langeard

    La Nouvelle Presse Medicale
    |November 18, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    APOE-ε4 genotype and western diet synergistically aggravate synaptic dysfunction in Alzheimer's disease via D-serine disruption.

    Alzheimer's research & therapy·2026
    Same author

    Cross-species dissection of the modular role of the ventral tegmental area in depressive disorders.

    Neuroscience·2025
    Same author

    Comparison of predictive validity of two autism spectrum disorder rat models: Behavioural investigations.

    Neurotoxicology·2024
    Same author

    Pharmacokinetic characterisation of a valproate Autism Spectrum Disorder rat model in a context of co-exposure to α-Hexabromocyclododecane.

    Environmental toxicology and pharmacology·2023
    Same author

    [Intraoperative photo of fluocinolone acetonide and dexamethasone implants].

    Journal francais d'ophtalmologie·2021
    Same author

    New injectable self-assembled hydrogels that promote angiogenesis through a bioactive degradation product.

    Acta biomaterialia·2020
    Same journal

    [Forms of intra-erythrocytes asexual multiplication of P. falciparium. Production of monoclonal antibodies].

    La Nouvelle presse medicale·2016
    Same journal

    [Cutaneous systemic angiitis in hairy cell leukemia].

    La Nouvelle presse medicale·1982
    Same journal

    [Isolated late epilepsy as manifestation of glioblastoma. True negative tests with the scanner].

    La Nouvelle presse medicale·1982
    Same journal

    [Non-specific benign ulcer of the colon. Arguments favoring its ischemic origin].

    La Nouvelle presse medicale·1982
    Same journal

    [Relation between psychological stress and obstetrical complications. Preliminary data].

    La Nouvelle presse medicale·1982
    Same journal

    [Significance of a "flat" curve of oral hyperglycemia. Comparison with a test meal].

    La Nouvelle presse medicale·1982
    See all related articles

    Dibekacin exhibits unique bronchial activity, differing from gentamicin but similar to amikacin. This suggests a specialized antibiotic transport mechanism into respiratory secretions.

    Area of Science:

    • Pharmacology
    • Respiratory Medicine
    • Infectious Diseases

    Background:

    • Aminoglycoside antibiotics are crucial for treating bacterial infections.
    • Understanding drug penetration into specific body sites, like bronchial secretions, is vital for optimizing therapy.
    • Dibekacin's pharmacokinetic profile in respiratory tissues requires further elucidation.

    Purpose of the Study:

    • To investigate the bronchial concentration and activity of dibekacin.
    • To compare dibekacin's bronchial pharmacokinetics with gentamicin and amikacin.
    • To explore the mechanism of dibekacin transport into bronchial secretions.

    Main Methods:

    • Bronchial fluid and serum samples were collected over time.
    • Antibiotic concentrations were measured using appropriate assays.

    Related Experiment Videos

  • The ratio of bronchial secretions to serum concentrations was analyzed.

    • Main Results:

    • Dibekacin demonstrated a distinct activity profile in bronchial secretions compared to gentamicin.
    • Dibekacin's bronchial peak lagged behind its serum peak by approximately three hours, similar to amikacin.
    • An increasing mucus/serum ratio over time indicated a specific transport mechanism into bronchial secretions.

    Conclusions:

    • Dibekacin possesses unique pharmacokinetic properties in the respiratory tract.
    • A specialized pathway facilitates dibekacin's passage from blood to bronchial secretions.
    • These findings may inform the use of dibekacin in treating respiratory tract infections.